Showing results (1771-1780 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|July 30, 2016
Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cellsBenjamin Rengstl, Frederike Schmid, Christian Weiser, et al.Oncoimmunology|July 30, 2016
Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cellsGregory J Baker, Peter Chockley, Daniel Zamler, et al.Oncoimmunology|July 30, 2016
CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesPhillip D Fromm, Michael S Papadimitrious, Jennifer L Hsu, et al.Oncoimmunology|July 30, 2016
The immune network in thyroid cancerMaria Rosaria Galdiero, Gilda Varricchi, Gianni MaroneOncoimmunology|July 30, 2016
A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formationGuoliang Zhang, Lin Guo, Cuixia Yang, et al.Oncoimmunology|July 30, 2016
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificityDavid Schirmer, Thomas G P Grünewald, Richard Klar, et al.Oncoimmunology|July 30, 2016
CorrigendumOncoimmunology|July 9, 2015
Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapySimone Kayser, Cristina Boβ, Judith Feucht, et al.Oncoimmunology|July 9, 2015
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistanceNathalie Vigneron, Nicolas van Baren, Benoît J Van den EyndeOncoimmunology|July 9, 2015
Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapyAnniek B van der Waart, Willemijn Hobo, Harry DolstraPageof 380